-
Thematic Analysis
NewAdvertising Sector Scorecard, Q1 2024 Update – Thematic Intelligence
Advertising has been caught up in the artificial intelligence (AI) frenzy and will be one of the industries most disrupted by AI. Generative AI is reshaping advertisers’ practices through tailored, effective ads and dynamic campaigns that evolve according to consumer response. As a result, the relationship between technology, artists, and brands paying for campaigns will profoundly change over the coming years. There is a real concern that advertisers will divert their money into AI-generated art rather than paying artists and...
-
Analyst Opinions
NewLuxury Travel – Key Trends and Market Analysis by Destinations, Challenges and Opportunities, 2024 Update
Luxury Travel Market Report Overview The luxury travel market includes lodging, airlines, travel agencies, and destinations. The luxury travel industry is anticipated to benefit from the growing number of high-net-worth individuals as this will help tourists take advantage of and enjoy upmarket products and services on subsequent trips. Post the relaxation of COVID-19-induced travel restrictions, the luxury travel industry has reinforced its outlook and started prioritizing customer experiences rather than material belongings. In addition to embracing sustainability and responsible travel...
-
Product Insights
NewLikelihood of Approval Analysis for Respiratory Syncytial Virus (RSV) Infections
Overview How likely is it that the drugs in Respiratory Syncytial Virus (RSV) Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Respiratory Syncytial Virus (RSV) Infections Overview Respiratory syncytial virus...
-
Product Insights
NewLikelihood of Approval Analysis for Urinary Tract Infections
Overview How likely is it that the drugs in Urinary Tract Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Urinary Tract Infections Overview A urinary tract infection (UTI) is a...
-
Product Insights
NewLikelihood of Approval Analysis for Human Papillomavirus Infections
Overview How likely is it that the drugs in Human Papillomavirus Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Human Papillomavirus Infections Overview Human Papillomavirus (HPV) infections are common sexually...
-
Product Insights
NewLikelihood of Approval Analysis for Mycoses
Overview How likely is it that the drugs in Mycoses will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mycoses Overview Mycoses, also known as fungal infections, encompass a diverse group of...
-
Product Insights
NewLikelihood of Approval Analysis for Enterovirus Infections
Overview How likely is it that the drugs in Enterovirus Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Enterovirus Infections Overview Enteroviruses are a group of viruses that cause various...
-
Product Insights
NewLikelihood of Approval Analysis for Genital Warts (Condylomata Acuminata)
Overview How likely is it that the drugs in Genital Warts (Condylomata Acuminata) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Genital Warts (Condylomata Acuminata) Overview Genital warts (condyloma acuminatum) are...
-
Product Insights
NewLikelihood of Approval Analysis for Bone Disorders
Overview How likely is it that the drugs in Bone Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bone Disorders Overview Bones tend to become weaker or loosen their strength...
-
Thematic Analysis
Artificial Intelligence (AI) in Clinical Practice – Patient Perspective – Thematic Intelligence
Artificial Intelligence (AI) in Clinical Practice Thematic Report Overview According to the survey, younger patients (18-55 years old) are more likely to be familiar with AI than the older (56+ years) patients as they have been exposed to technologies such as computers and smart devices from a younger age and thus, may be more comfortable with innovation use. Following this trend, patients familiar with AI selected more advantages associated with AI implementation in clinical practice compared to those unfamiliar with this technology. This...